Concepedia

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

José Valdez Madruga, Daniel Berger, Marilyn McMurchie, Fredy Suter, Dénes Bánhegyi, Kiat Ruxrungtham, Dorece Norris, Éric Lefebvre, Marie-Pierre de Béthune, Frank Tomaka,

The Lancet · 2007 · 332 citations · 12 references

Concepts

PharmacyInfectious DiseasesPharmacotherapyClinical PharmacologyVirologyAntiretroviral TherapyAntiviral AgentsAntiviral PharmacologyAntiviral PharmacotherapyAntiviral TherapyHuman Immunodeficiency Virus PharmacotherapyAntiretroviral ResponseAntiviral Safety AssessmentHiv Antiretroviral TherapyPharmacodynamics Of Antiretroviral Therapy

References

12

UPDATE ON DRUG RESISTANCE MUTATIONS IN HIV-1

&NA; · Infectious Diseases in Clinical Practice · 2001 · 1.7K citations

Life Sciences, Genetics, Molecular Genetics +17

British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008

B G Gazzard · HIV Medicine · 2008 · 1.1K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Treatment for Adult HIV Infection

Scott M. Hammer, Michael S. Saag, Mauro Schechter et al. · JAMA · 2006 · 1K citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +15

Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America

Jacob Lalezari, Keith Henry, Mary O’Hearn et al. · New England Journal of Medicine · 2003 · 915 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacotherapy +16

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

Bonaventura Clotet, Nicholas Bellos, Jean‐Michel Molina et al. · The Lancet · 2007 · 480 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +11